Drug · DIN 02484048 · Radiopharmaceutical
CERETEC
WITH COBALT STABILIZER SOLUTION
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 15, 2019; first marketed April 15, 2019.
- Drug Identification Number (DIN)
- 02484048
- Company (DIN owner)
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule c
- Dosage form
- Kit; Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- TECHNETIUM (99m Tc) EXAMETAZIME LABELLED CELLS V09HA02
- Class
- Radiopharmaceutical
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EXAMETAZIME | 0.5 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 21, 2018: NOC 21643Supplement to a New Drug Submission (SNDS) · New stabilizer solution
Other DINs named CERETEC
- DIN 02329034 · Marketed